Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Iain A. Stuart
Age : 48
Public asset : 5,332 USD
Linked companies : VYNE Therapeutics Inc.
Presently, Iain A. Stuart holds the position of Chief Scientific Officer at VYNE Therapeutics, Inc.

He previously occupied the position of Project Manager-Pharmaceutical Development at Cyclacel Pharmaceuticals, Inc., Chief Research & Development Officer at VYNE Pharmaceuticals Ltd., Chief Scientific Officer at Menlo Therapeutics, Inc., Senior Director-Study at Inveresk Research Group, Inc. and VP-Medical Strategy & Scientific Affairs at Leo Pharma, Inc.

He received a doctorate and an undergraduate degree from Glasgow Caledonian University.

Current positions of Iain A. Stuart 
NameTitle Since
VYNE Therapeutics Inc.
Chief Scientific Officer -

Holdings of Iain A. Stuart 
VYNE Therapeutics Inc. (VYNE)
13,7070.024%5,332 USD

Iain A. Stuart: Personal Network 
Most Read News 
07/27AMANCIO ORTEGA : Inditex founder Ortega buys 5% in Enagas's renewable, hydrogen unit
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
07/26MARK ZUCKERBERG : As Zuckerberg bets on TikTok-style videos, Meta heads for first-ever revenue drop
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
07/26ELON MUSK : Elon Musk asks judge for Twitter trial on Oct. 17, not Oct. 10
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
07/28JACK MA : Jack Ma plans to give up control of Ant Group - WSJ
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
More news

© 2022 People and Ownership :   
Iain A. Stuart : Connections